Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines

  • The PLOS ONE Staff

Notice of republication

This article was republished on March 31, 2023, to correct for errors in the Data Availability statement. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0317835.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0317835.s002

(PDF)

Reference

  1. 1. Mascia F, Mazo I, Alterovitz W-L, Karagiannis K, Wu WW, Shen R-F, et al. (2022) In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines. PLoS ONE 17(1): e0262134. https://doi.org/10.1371/journal.pone.0262134 pmid:34990474

Citation: The PLOS ONE Staff (2025) Correction: In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines. PLoS ONE 20(1): e0317835. https://doi.org/10.1371/journal.pone.0317835

Published: January 15, 2025

Copyright: © 2025 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.